TAKEDA PHARM.CO.LTD./ JP3463000004 /
2024-05-31 9:19:18 PM | Chg. +0.340 | Volume | Bid10:01:53 PM | Ask10:01:53 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
24.540EUR | +1.40% | 4,254 Turnover: 103,778.810 |
24.510Bid Size: 410 | 24.750Ask Size: 406 | 38.96 bill.EUR | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 204.29 JPY | 38.84% |
EPS Diluted: | - JPY | 38.44% |
Revenues per Share: | 2,545.34 JPY | 12.84% |
Book Value per Share: | 4,015.76 JPY | 11.81% |
Cash Flow per Share: | 617.56 JPY | -13.00% |
Dividend per Share: | 180.00 JPY | 0.00% |
Total | in mill. | |
Revenues: | 4,027,478.00 JPY | 12.85% |
Net Income: | 317,017.00 JPY | 37.80% |
Operating Cash Flow: | 977,156.00 JPY | - |
Cash and Cash Equivalents: | 533,530.00 JPY | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 20.43 | 21.29 |
P/S Ratio: | 1.64 | 1.71 |
P/BV ratio: | 1.04 | 1.08 |
P/CF Ratio: | 6.76 | 7.04 |
PEG: | 0.53 | 0.55 |
Earnings Yield: | 4.90% | 4.70% |
Dividend Yield: | 4.31% | 4.14% |
Market Capitalization | ||
Market Capitalization: | 38.96 bill. EUR | 44.05 bill. EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | 822,802.6220 EUR | 930,388.8596 EUR |
Shares Outstanding: | 1.58 bill. |
Profitability
Gross Profit Margin: | 69.11% |
EBIT Margin: | 12.18% |
Net Profit Margin: | 7.87% |
Return on Equity: | 4.99% |
Return on Assets: | 2.27% |
Financial Strength
Liquidity I / Cash Ratio: | 21.50% |
Liquidity II / Quick Ratio: | 47.66% |
Liquidity III / Current Ratio: | 96.62% |
Debt / Equity Ratio: | 119.66% |
Dynam. Debt / Equity Ratio: | 778.14% |
Efficiency
Employees: | 47,347 |
Personal Expenses / Employee: | - JPY |
Revenues / Employee: | 85,063,002.94 JPY |
Net Income / Employee: | 6,695,609.01 JPY |
Total Assets / Employee: | 294,796,924.83 JPY |
* Fiscal Year End: | 2023-03-31 |
Accounting Standard: | IFRS |
Currency: | JPY |